Pulmotect Secures $1,751,430 Series A Financing Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=9d25722b-94d3-4b99-86cb-39edd683c781
Date
5/9/2016
Company Name
Pulmotect
Mailing Address
3900 Essex Ln. Houston, TX 77027 USA
Company Description
Pulmotect, Inc. is a Houston-based biotechnology company, developing products that boost the innate immune system to protect against a wide range of lung infections. Our cofounders are leaders in the emerging science of innate immunity in the lungs.
Website
http://www.pulmotect.com
Transaction Type
Venture Equity
Transaction Amount
$1,751,430
Transaction Round
Series A
Proceeds Purposes
Proceeds purposes were not disclosed. 5 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
M&A Terms
Venture Investor
Undisclosed